Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1994 Dec;32(12):3078-81.
doi: 10.1128/jcm.32.12.3078-3081.1994.

Severe osteomyelitis due to the zygomycete Apophysomyces elegans

J F Meis  1 , B J Kullberg, M Pruszczynski, R P Veth
Affiliations
Review

Severe osteomyelitis due to the zygomycete Apophysomyces elegans

J F Meis et al. J Clin Microbiol. 1994 Dec.

Abstract

We describe a previously healthy 69-year-old man presenting with osteomyelitis of the humerus due to the zygomycete Apophysomyces elegans. The infection was acquired in Aruba, The Netherlands Antilles. The skin provided the most likely portal of entry, although there was no history of a traumatic inoculation. The patient had no history of diabetes, and no underlying immune defects were found. Despite treatment with 7.9 g of amphotericin B, an interthoracoscapular amputation proved necessary to curtail the rapid spread of the fungus in this immunocompetent host.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Osteoarticular Mycoses.
    Gamaletsou MN, Rammaert B, Brause B, Bueno MA, Dadwal SS, Henry MW, Katragkou A, Kontoyiannis DP, McCarthy MW, Miller AO, Moriyama B, Pana ZD, Petraitiene R, Petraitis V, Roilides E, Sarkis JP, Simitsopoulou M, Sipsas NV, Taj-Aldeen SJ, Zeller V, Lortholary O, Walsh TJ; International Consortium for Osteoarticular Mycoses. Gamaletsou MN, et al. Clin Microbiol Rev. 2022 Dec 21;35(4):e0008619. doi: 10.1128/cmr.00086-19. Epub 2022 Nov 30. Clin Microbiol Rev. 2022. PMID: 36448782 Free PMC article. Review.
  • Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis.
    Dannaoui E, Mouton JW, Meis JF, Verweij PE; Eurofung Network. Dannaoui E, et al. Antimicrob Agents Chemother. 2002 Jun;46(6):1953-9. doi: 10.1128/AAC.46.6.1953-1959.2002. Antimicrob Agents Chemother. 2002. PMID: 12019114 Free PMC article.
  • Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern.
    Chakrabarti A, Shivaprakash MR, Curfs-Breuker I, Baghela A, Klaassen CH, Meis JF. Chakrabarti A, et al. J Clin Microbiol. 2010 Dec;48(12):4580-5. doi: 10.1128/JCM.01420-10. Epub 2010 Sep 29. J Clin Microbiol. 2010. PMID: 20881165 Free PMC article.
  • Apophysomyces elegans: an emerging zygomycete in India.
    Chakrabarti A, Ghosh A, Prasad GS, David JK, Gupta S, Das A, Sakhuja V, Panda NK, Singh SK, Das S, Chakrabarti T. Chakrabarti A, et al. J Clin Microbiol. 2003 Feb;41(2):783-8. doi: 10.1128/JCM.41.2.783-788.2003. J Clin Microbiol. 2003. PMID: 12574283 Free PMC article.
  • Mucormycosis spondylodiscitis after lumbar disc puncture.
    Chen F, Lü G, Kang Y, Ma Z, Lu C, Wang B, Li J, Liu J, Li H. Chen F, et al. Eur Spine J. 2006 Mar;15(3):370-6. doi: 10.1007/s00586-005-1025-0. Epub 2005 Nov 18. Eur Spine J. 2006. PMID: 16328227 Free PMC article.
See all "Cited by" articles

References

    1. Medicine (Baltimore). 1977 Nov;56(6):475-82 - PubMed
    1. Clin Infect Dis. 1994 Aug;19(2):329-31 - PubMed
    1. N Engl J Med. 1978 Nov 16;299(20):1115-8 - PubMed
    1. Arch Intern Med. 1979 May;139(5):557-60 - PubMed
    1. Hum Pathol. 1980 Sep;11(5):457-64 - PubMed

LinkOut - more resources